Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Ihne

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Heart Failure Reports|November 30, 2019
Amyloidosis in Heart FailureSandra Ihne, Caroline Morbach, Laura Obici, et al.
Deutsches Arzteblatt International|April 17, 2020
Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed DiseaseSandra Ihne, Caroline Morbach, Claudia Sommer, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 11, 2021
Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-typeAikaterini Papagianni, Sandra Ihne, Daniel Zeller, et al.
Journal of Neurochemistry|November 6, 2020
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosisMaike F Dohrn, Sandra Ihne, Ute Hegenbart, et al.
Oncotarget|May 30, 2019
Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationDeborah Backs, Ilknur Saglam, Claudia Löffler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2019
Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphyMalte Kircher, Sandra Ihne, Joachim Brumberg, et al.
BMC Cardiovascular Disorders|November 14, 2025
Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosisVladimir Cejka, Clemens Hosp, Maximilian Steinhardt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Heart Failure Reports|November 30, 2019
Amyloidosis in Heart FailureSandra Ihne, Caroline Morbach, Laura Obici, et al.
Deutsches Arzteblatt International|April 17, 2020
Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed DiseaseSandra Ihne, Caroline Morbach, Claudia Sommer, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 11, 2021
Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-typeAikaterini Papagianni, Sandra Ihne, Daniel Zeller, et al.
Journal of Neurochemistry|November 6, 2020
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosisMaike F Dohrn, Sandra Ihne, Ute Hegenbart, et al.
Oncotarget|May 30, 2019
Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationDeborah Backs, Ilknur Saglam, Claudia Löffler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2019
Detection of cardiac amyloidosis with <sup>18</sup>F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphyMalte Kircher, Sandra Ihne, Joachim Brumberg, et al.
BMC Cardiovascular Disorders|November 14, 2025
Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosisVladimir Cejka, Clemens Hosp, Maximilian Steinhardt, et al.
Pageof 1